ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

CHF-6467

Also written as “CHF6467 Part 1 (SAD)”, “CHF6467 Part 2 (MAD)” and “CHF6467 active”.

Its studies are mostly in Diabetic Foot, led by Chiesi Farmaceutici.

Drug pageCHF-6467: every studyAll 3 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 2, since Mar 28, 20192 company-led studies, 1 open or runningNext primary completion: Feb 28, 2027 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Chiesi Farmaceutici21 open or runningphase 2since Mar 28, 2019Mar 28, 2019Feb 28, 2027phase 1 · NCT07163182

Also a collaborator on its studies: Comac Medical.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 28, 2019First study: phase 2 study in Diabetic FootFirst studyNCT04077671 · 93 enrolled · Bulgaria
  2. Jul 24, 2025Phase 1 study in Healthy VolunteersNCT07163182 · 68 planned · Bulgaria

Ahead

  1. Feb 28, 2027Primary completion: phase 1 study in Healthy VolunteersNCT07163182

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07163182Healthy Volunteers · Bulgaria1RecruitingFeb 28, 202768
NCT04077671Diabetic Foot · Bulgaria2CompletedJan 7, 202193

How it is read

Names in the registry

  • “CHF6467 Part 1 (SAD)”, 1 entry
  • “CHF6467 Part 2 (MAD)”, 1 entry
  • “CHF6467 active”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.